These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 9042229

  • 21. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
    Bellamy WT, Odeleye A, Huizenga E, Dalton WS, Weinstein RS, Grogan TM.
    Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
    [Abstract] [Full Text] [Related]

  • 22. In vivo reversibility of multidrug resistance by the MDR-modulator dexniguldipine (niguldipine derivative B859-35) and by verapamil.
    Dietel M, Boss H, Reymann A, Pest S, Seidel A.
    J Exp Ther Oncol; 1996 Jan; 1(1):23-9. PubMed ID: 9414385
    [Abstract] [Full Text] [Related]

  • 23. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
    Mi Q, Cui B, Silva GL, Lantvit D, Lim E, Chai H, You M, Hollingshead MG, Mayo JG, Kinghorn AD, Pezzuto JM.
    Cancer Res; 2001 May 15; 61(10):4030-7. PubMed ID: 11358822
    [Abstract] [Full Text] [Related]

  • 24. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.
    Cayre A, Moins N, Finat-Duclos F, Verrelle P, Maublant J.
    J Nucl Med; 1997 Nov 21; 38(11):1674-7. PubMed ID: 9374331
    [Abstract] [Full Text] [Related]

  • 30. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
    Gopinath VS, Thimmaiah P, Thimmaiah KN.
    Bioorg Med Chem; 2008 Jan 01; 16(1):474-87. PubMed ID: 17933543
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intravitreal daunomycin induces multidrug resistance in proliferative vitreoretinopathy.
    Esser P, Tervooren D, Heimann K, Kociok N, Bartz-Schmidt KU, Walter P, Weller M.
    Invest Ophthalmol Vis Sci; 1998 Jan 01; 39(1):164-70. PubMed ID: 9430558
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells.
    Huet S, Chapey C, Robert J.
    Eur J Cancer; 1993 Jan 01; 29A(10):1377-83. PubMed ID: 8398262
    [Abstract] [Full Text] [Related]

  • 39. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y, Harel-Orbital T, Gaffield W, Liscovitch M.
    Anticancer Res; 2001 Jan 01; 21(2A):1189-94. PubMed ID: 11396162
    [Abstract] [Full Text] [Related]

  • 40. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax.
    Li X, Hong L, Zhao Y, Jin H, Fan R, Du R, Xia L, Luo G, Fan D.
    Biochem Cell Biol; 2007 Dec 01; 85(6):741-50. PubMed ID: 18059532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.